Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fuji
Chubb
Healthtrust
Teva
Julphar
AstraZeneca
Medtronic
Moodys

Generated: April 19, 2018

DrugPatentWatch Database Preview

ALOCRIL Drug Profile

« Back to Dashboard

Which patents cover Alocril, and what generic alternatives are available?

Alocril is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in ALOCRIL is nedocromil sodium. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the nedocromil sodium profile page.
Drug patent expirations by year for ALOCRIL
Pharmacology for ALOCRIL
Medical Subject Heading (MeSH) Categories for ALOCRIL
Synonyms for ALOCRIL
4H-Pyrano(3,2-g)quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, disodium salt
69049-73-6 (Parent)
69049-74-7
Abrevia
AC1L18TW
AK326157
AKOS015909770
Alocril (TN)
AN-37980
API0003522
BC202813
C19H16NO7.Na
CHEBI:7493
CHEMBL915
D00527
DISODIUM 9-ETHYL-4,6-DIOXO-10-PROPYL-4H,6H,9H-CHROMENO[7,6-B]PYRIDINE-2,8-DICARBOXYLATE
disodium 9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylate
disodium 9-ethyl-4,6-dioxo-10-propyl-pyrano[3,2-g]quinoline-2,8-dicarboxylate
disodium 9-ethyl-4,6-dioxo-10-propylpyrano[3,2-g]quinoline-2,8-dicarboxylate
disodium 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano-[3,2-g]-quinoline-2,8-dicarboxylate
Disodium-9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylate
DTXSID00219115
ET8IF4KS1T
FPL 59002KP
FPL-59002KP
FT-0603491
I14-31884
JQEKDNLKIVGXAU-UHFFFAOYSA-L
LS-127533
NEDOCROMIL SODIUM
Nedocromil sodium (USAN)
Nedocromil sodium [USAN]
PL008390
Rapitil
SCHEMBL24944
Sodium 9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylate
Tilade
Tilade (TN)
Tilarin
Tilavist
TRA0037647
UNII-ET8IF4KS1T
VA11365

US Patents and Regulatory Information for ALOCRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 AT RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ALOCRIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Medtronic
Cerilliant
Julphar
Deloitte
Baxter
Argus Health
Chubb
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.